Bernard Herzog, MD in Chippewa Fls, WI - Surgery

Bernard Herzog, MD is a Surgery physician based in Chippewa Fls, Wisconsin. Bernard Herzog is licensed to practice in Wisconsin (license number 26664) and his current practice location is 2655 Cty Hwy 1, Chippewa Fls, Wisconsin. He can be reached at his office (for appointments etc.) via phone at (715) 726-4160.

NPI number for Bernard Herzog is 1265540520 and his current mailing address is 1000 N Oak Ave, Marshfield, Wisconsin. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1265540520.

Contact Information

	Bernard Herzog, MD
	2655 Cty Hwy 1, Chippewa Fls, WI 54729
	(715) 726-4160
	Not Available

Physician's Profile

Full Name	Bernard Herzog
Gender	Male
Speciality	Surgery
Location	2655 Cty Hwy 1, Chippewa Fls, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1265540520
Provider Enumeration Date: 08/28/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Bernard Herzog such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265540520	NPI	-	NPPES
30645300	Medicaid	WI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	26664 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bernard Herzog is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Bernard Herzog, MD 1000 N Oak Ave, Marshfield, WI 54449-5777 Ph: () -	Bernard Herzog, MD 2655 Cty Hwy 1, Chippewa Fls, WI 54729 Ph: (715) 726-4160

News Archive

FDA provides guidance on Restanza clinical program in treatment of CABP

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic, in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia.

Oxidative stress could lead to health problems and premature death

If you aren't getting a good, consistent and regular night's sleep, a new study suggests it could reduce your ability to handle oxidative stress, cause impacts to your health, increase motor and neurological deterioration, speed aging and ultimately cut short your life.

Grow ornamental plants to remove indoor air pollutants

Air quality in homes, offices, and other indoor spaces is becoming a major health concern, particularly in developed countries where people often spend more than 90% of their time indoors. Surprisingly, indoor air has been reported to be as much as 12 times more polluted than outdoor air in some areas. Indoor air pollutants emanate from paints, varnishes, adhesives, furnishings, clothing, solvents, building materials, and even tap water.

Prevention and partnerships are the keys to improving health and reducing chronic disease in the United States

Prevention and partnerships are the keys to improving health and reducing chronic disease in the United States and throughout the Americas, a Pan American Health Organization official said today.

Bernard Herzog, MD - Surgery in Chippewa Fls, WI